RecruitingPhase 2NCT07172659
8
studies recruiting now
as of 7 Sept 2026
52
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
7 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06599411
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
RecruitingPhase 3NCT05597280
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
RecruitingNot applicableNCT07515989
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
RecruitingNot applicableNCT06222372
Novel Interventions and Diagnostic Tests for Leprosy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 8 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Leprosy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Leprosy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
3 approved treatments and 5 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Clofazimine (Lamprene)Approved: Dapsone (Aczone)Approved: Sulfoxone Sodium (Diasone sodium)
Phase 3Bedaquiline
Phase 3Rifampin (Eremfat)
Phase 2/3Cyclosporine (Capimune)
Phase 2/3Prednisolone (Cortalone)
Phase 2Metformin
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).